Polymorphisms in ERCC2 and overall survival (OS) in early stage non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Suk, R
Park, S
Liu, G
Cogan-Drew, T
Zhou, W
Su, L
Lynch, T
Wain, J
Christiani, D
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：842S / 842S
页数：1
相关论文
共 50 条
  • [1] Disease-free survival (DFS) as a predictor of overall survival (OS) in completely resected early stage non-small cell lung cancer (NSCLC)
    West, H.
    Hu, X.
    Burke, T.
    Walker, M. S.
    Wang, Y.
    Samkari, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S74 - S75
  • [2] Treatment patterns, overall survival (OS), and disease-free survival (DFS) in early stage non-small cell lung cancer (NSCLC) following complete resection
    West, H.
    Hu, X.
    Burke, T.
    Walker, M. S.
    Wang, Y.
    Samkari, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S74 - S74
  • [3] Polymorphisms in the caspase genes and survival of early stage non-small cell lung cancer
    Lee, Shin Yup
    Choi, Jin Eun
    Lee, Won Kee
    Choi, Yi Young
    Jeon, Hyo Sung
    Kim, Dong Sun
    Han, Sung Beom
    Jheon, Sanghoon
    Park, Jae Yong
    Yoo, Seung Soo
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S508 - S509
  • [4] MDM2 polymorphism and recurrence-free and overall survival in early stage non-small cell lung cancer (NSCLC).
    Heist, R. Suk
    Zhou, W.
    Cogan-Drew, T.
    Liu, G.
    Su, L.
    Neuberg, D.
    Lynch, T. J.
    Wain, J. C.
    Christiani, D. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 419S - 419S
  • [5] Overall Survival (OS) of Pathological N2 Non-Small Cell Lung Cancer (NSCLC) After Surgical Resection
    Bourdages-Pageau, E.
    Vieira, A.
    Labbe, C.
    Figueroa, P. Ugalde
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2233 - S2233
  • [6] Genetic polymorphisms correlate with overall survival (OS) in advanced non-small cell lung cancer (NSCLC) treated with carboplatin (CBDCA) and paclitaxel (PTX)
    Yamamoto, N.
    Sato, Y.
    Tamura, T.
    Kunitoh, H.
    Ohe, Y.
    Katori, N.
    Sawada, J.
    Sekine, A.
    Nakamura, Y.
    Saijo, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Polymorphisms in ERCC1 and XPF gene and response to chemotherapy and overall survival of non-small cell lung cancer
    Shi, Zong-Hua
    Shi, Guang-Yong
    Liu, Lin-Gang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (03): : 3132 - 3137
  • [8] A nomogram to predict overall survival of patients with early stage non-small cell lung cancer
    Zhang, Jiahui
    Fan, Jingyi
    Yin, Rong
    Geng, Liguo
    Zhu, Meng
    Shen, Wei
    Wang, Yuzhuo
    Cheng, Yang
    Li, Zhihua
    Dai, Juncheng
    Jin, Guangfu
    Hu, Zhibin
    Ma, Hongxia
    Xu, Lin
    Shen, Hongbing
    JOURNAL OF THORACIC DISEASE, 2019, 11 (12) : 5407 - 5416
  • [9] Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice
    Martin Faehling
    Birgit Schwenk
    Sebastian Kramberg
    Sabine Fallscheer
    Matthias Leschke
    Jörn Sträter
    Robert Eckert
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 2059 - 2066
  • [10] Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice
    Faehling, Martin
    Schwenk, Birgit
    Kramberg, Sebastian
    Fallscheer, Sabine
    Leschke, Matthias
    Straeter, Joern
    Eckert, Robert
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (10) : 2059 - 2066
12345